Skip to Content
HCA Midwest Health

Clinical Research Trials

The clinical research program at HCA Midwest Health in Kansas City helps our doctors discover new ways to prevent, detect, and treat various diseases and conditions.

Clinical Trials

HCA Midwest Health currently has 24 clinical cancer trials available. Our clinical research program looks at new ways to prevent, detect, or treat disease.

View our clinical research program 


CDC guidance now recommends that moderately to severely immunocompromised patients receive an additional (third) dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech or Moderna). If you have undergone anti-cancer therapy in the past year, you are within 1 year of stem cell transplantation or are receiving medications that suppress your immune system, you are encouraged to obtain a third COVID-19 vaccination shot. If you received the Johnson & Johnson single dose vaccination, please consult your doctor regarding next steps. Find vaccination locations here.

If you are within 100 days of a stem cell transplantation, we do not recommend that you receive a COVID-19 vaccination until you are cleared by your care team to do so. If you are currently on a clinical research trial, please contact your clinical research team for more guidance. Please contact your care coordinator if you have additional questions about receiving an additional COVID-19 vaccine shot.

Find a vaccination site